{"id":"https://openalex.org/W3209972002","doi":"https://doi.org/10.1111/dom.14582","title":"A model\u2010based simulation of glycaemic control and body weight when switching from semaglutide to 3.0\u2010 and 4.5\u2010mg doses of once\u2010weekly dulaglutide","display_name":"A model\u2010based simulation of glycaemic control and body weight when switching from semaglutide to 3.0\u2010 and 4.5\u2010mg doses of once\u2010weekly dulaglutide","alternate_titles":[],"publication_year":2021,"publication_date":"2021-10-25","ids":{"openalex":"https://openalex.org/W3209972002","doi":"https://doi.org/10.1111/dom.14582","mag":"3209972002","pmid":"https://pubmed.ncbi.nlm.nih.gov/34697882","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9298861"},"language":"en","primary_location":{"id":"doi:10.1111/dom.14582","doi":"https://doi.org/10.1111/dom.14582","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.14582","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3209972002"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1111/dom.14582","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022862627","display_name":"Lai San Tham","orcid":"https://orcid.org/0000-0002-1249-8526","observed_orcids":["https://orcid.org/0000-0002-1249-8526"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lai San Tham","raw_affiliation_strings":["Lilly Centre for Clinical Pharmacology, Singapore"],"raw_orcid":"https://orcid.org/0000-0002-1249-8526","affiliations":[{"raw_affiliation_string":"Lilly Centre for Clinical Pharmacology, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089515974","display_name":"Kevin M. Pantalone","orcid":"https://orcid.org/0000-0002-3897-4551","observed_orcids":["https://orcid.org/0000-0002-3897-4551"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin M. Pantalone","raw_affiliation_strings":["Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio, USA"],"raw_orcid":"https://orcid.org/0000-0002-3897-4551","affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007315645","display_name":"Kathleen Marie Dungan","orcid":"https://orcid.org/0000-0003-1289-1595","observed_orcids":["https://orcid.org/0000-0003-1289-1595"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Dungan","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, Ohio, USA"],"raw_orcid":"https://orcid.org/0000-0003-1289-1595","affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, Ohio, USA","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009114082","display_name":"Kashif M. Munir","orcid":"https://orcid.org/0000-0002-1075-1284","observed_orcids":["https://orcid.org/0000-0002-1075-1284","https://orcid.org/0009-0002-5089-1983"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kashif Munir","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":"https://orcid.org/0000-0002-1075-1284","affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103154520","display_name":"Cheng Cai Tang","orcid":"https://orcid.org/0000-0003-3052-393X","observed_orcids":["https://orcid.org/0000-0003-3052-393X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheng Cai Tang","raw_affiliation_strings":["Lilly Centre for Clinical Pharmacology, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Centre for Clinical Pharmacology, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077985126","display_name":"\u041c\u0430\u043d\u0438\u0433\u0435 \u041a\u043e\u043d\u0438\u0433","orcid":"https://orcid.org/0000-0002-1584-8309","observed_orcids":["https://orcid.org/0000-0002-1584-8309"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manige Konig","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":"https://orcid.org/0000-0002-1584-8309","affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021162116","display_name":"Anita Y. M. Kwan","orcid":"https://orcid.org/0000-0003-4696-5388","observed_orcids":["https://orcid.org/0000-0003-4696-5388"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anita Y. M. Kwan","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5022862627"],"corresponding_institution_ids":[],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":{"value":4700,"currency":"USD","value_usd":4700},"fwci":1.3308,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.78074918,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"24","issue":"2","first_page":"302","last_page":"311"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9039999842643738},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7039999961853027},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6800000071525574},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9810000061988831},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7919999957084656},{"id":"https://openalex.org/keywords/drug-switching","display_name":"drug switching","score":0.6629999876022339},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.6940000057220459},{"id":"https://openalex.org/keywords/sustain-trials","display_name":"SUSTAIN trials","score":0.7749999761581421},{"id":"https://openalex.org/keywords/weight-loss-maintenance","display_name":"weight loss maintenance","score":0.47699999809265137},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9880924820899963},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.9683102965354919},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.5960690379142761},{"id":"https://openalex.org/C140793950","wikidata":"https://www.wikidata.org/wiki/Q168091","display_name":"Animal science","level":1,"score":0.512432873249054},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4526597261428833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4223180413246155},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40279123187065125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.265145868062973},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.25586315989494324},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.19652754068374634},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.17861410975456238},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.158419668674469},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1440160572528839},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07841518521308899},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.050069063901901245}],"mesh":[{"descriptor_ui":"D000085002","descriptor_name":"Glycemic Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/dom.14582","doi":"https://doi.org/10.1111/dom.14582","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.14582","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9298861","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9298861/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9298861/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:34697882","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34697882","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/dom.14582","doi":"https://doi.org/10.1111/dom.14582","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.14582","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3209972002.pdf","grobid_xml":"https://content.openalex.org/works/W3209972002.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1967221084","https://openalex.org/W2009795777","https://openalex.org/W2023148868","https://openalex.org/W2166886145","https://openalex.org/W2210133271","https://openalex.org/W2267596322","https://openalex.org/W2519510391","https://openalex.org/W2563047690","https://openalex.org/W2572398654","https://openalex.org/W2602700371","https://openalex.org/W2604469807","https://openalex.org/W2774157762","https://openalex.org/W2787255324","https://openalex.org/W2801715295","https://openalex.org/W2807957707","https://openalex.org/W2883897596","https://openalex.org/W2887502192","https://openalex.org/W2893065478","https://openalex.org/W2896668644","https://openalex.org/W2918407168","https://openalex.org/W2973758715","https://openalex.org/W2974008202","https://openalex.org/W3024880155","https://openalex.org/W3087290101","https://openalex.org/W3088988988","https://openalex.org/W3114726363","https://openalex.org/W3119307884","https://openalex.org/W3184801395"],"related_works":["https://openalex.org/W3174163049","https://openalex.org/W2883897596","https://openalex.org/W4392155519","https://openalex.org/W4410879295","https://openalex.org/W4390600128","https://openalex.org/W4221087049","https://openalex.org/W2977069026","https://openalex.org/W3184801395","https://openalex.org/W7144871340","https://openalex.org/W4408764347"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"evaluate":[2],"HbA1c":[3,27,58,119,153,176,223],"and":[4,28,35,48,59,75,98,120,130,144,154,166,224],"body":[5,29,60],"weight":[6,30,61,121,155,181,225,238],"changes":[7,115,156],"when":[8,195],"semaglutide":[9,47,70,123,158,198,208,229],"0.5-":[10,78],"or":[11,20,79,95,102,214],"1.0-mg":[12,80],"once-weekly":[13],"(QW)":[14],"is":[15],"switched":[16],"to":[17,43,77,100,128,136,172,185,201,211,232],"dulaglutide":[18,91,137,173,202,212,233],"3.0-":[19,101],"4.5-mg":[21,103],"QW":[22,81,97,104],"via":[23,82,105],"exposure-response":[24],"modelling.":[25],"METHODS:":[26],"time-course":[31],"models":[32],"were":[33,55,126,142,164],"developed":[34],"validated":[36],"with":[37,179,217],"data":[38],"from":[39,116,197,207,228],"the":[40,49,66],"SUSTAIN":[41],"1":[42],"10":[44],"trials":[45],"for":[46,52,57,122,157],"AWARD-11":[50],"trial":[51],"dulaglutide.":[53],"Simulations":[54],"conducted":[56],"over":[62],"52":[63,149,189],"weeks.":[64,150,190],"In":[65],"initial":[67],"26":[68,88,111,162],"weeks,":[69,112],"was":[71,177,193],"initiated":[72,92],"at":[73,93,148,161,188],"0.25-mg":[74],"titrated":[76],"4-weekly":[83,106],"stepwise":[84,107],"titration,":[85],"followed":[86],"by":[87],"weeks":[89,163],"of":[90,183],"0.75-":[94],"1.5-mg":[96],"escalated":[99],"titration.":[108],"RESULTS:":[109],"At":[110],"model-predicted":[113],"mean":[114,152],"baseline":[117],"in":[118],"0.5":[124,209],"mg":[125,160,200,210,216,231,235],"up":[127,184],"-1.55%":[129],"-3.44":[131],"kg,":[132,146,168],"respectively.":[133],"After":[134],"switching":[135,171,196,227],"3.0":[138,203,213],"mg,":[139,175],"further":[140],"reductions":[141],"0.19%":[143],"1.40":[145],"respectively,":[147],"Predicted":[151],"1.0":[159,199,230],"-1.84%":[165],"-4.96":[167],"respectively;":[169],"after":[170],"4.5":[174,215,234],"maintained":[178],"additional":[180,222],"reduction":[182],"0.57":[186],"kg":[187],"Glycaemic":[191],"control":[192],"preserved":[194],"mg.":[204],"CONCLUSION:":[205],"Switching":[206],"dose":[218],"escalation":[219],"potentially":[220],"yields":[221],"reductions;":[226],"may":[236],"enhance":[237],"loss.":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3209972002","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2021-11-08T00:00:00"}
